These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Over-expression of p55Cdc inhibits granulocyte differentiation and accelerates apoptosis in myeloid cells. Kao CT; Lin M; O'Shea-Greenfield A; Weinstein J; Sakamoto KM Oncogene; 1996 Sep; 13(6):1221-9. PubMed ID: 8808696 [TBL] [Abstract][Full Text] [Related]
25. A recombinant fusion toxin targeted to the granulocyte-macrophage colony-stimulating factor receptor. Bendel AE; Shao Y; Davies SM; Warman B; Yang CH; Waddick KG; Uckun FM; Perentesis JP Leuk Lymphoma; 1997 Apr; 25(3-4):257-70. PubMed ID: 9168436 [TBL] [Abstract][Full Text] [Related]
26. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia. Lee J; Kim Y; Lim J; Kim M; Han K Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925 [TBL] [Abstract][Full Text] [Related]
27. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. Iwasaki-Arai J; Iwasaki H; Miyamoto T; Watanabe S; Akashi K J Exp Med; 2003 May; 197(10):1311-22. PubMed ID: 12756267 [TBL] [Abstract][Full Text] [Related]
28. Cellular characteristics of chronic myelocytic leukemia basophilic crisis cells: phenotype, responsiveness to and receptor gene expression for various kinds of growth factors and cytokines. Shimizu N; Kita K; Masuya M; Nishii K; Matsuoka N; Morita N; Miwa H; Shirakawa S Exp Hematol; 1993 Jan; 21(1):119-25. PubMed ID: 7678084 [TBL] [Abstract][Full Text] [Related]
29. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells. Ferret-Bernard S; Saï P; Bach JM Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293 [TBL] [Abstract][Full Text] [Related]
30. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165 [TBL] [Abstract][Full Text] [Related]
31. Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells. Murohashi I; Yoshida K; Kishimoto K; Takahashi T; Wakao D; Jinnai I; Yagasaki F; Kawai N; Suzuki T; Matsuda A; Hirashima K; Bessho M J Interferon Cytokine Res; 2002 Mar; 22(3):335-41. PubMed ID: 12034041 [TBL] [Abstract][Full Text] [Related]
32. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor. Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577 [TBL] [Abstract][Full Text] [Related]
33. DNA methylation does not regulate JUNB expression in CML: comment on "Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia" by Hoshino et al. [Leuk. Res. 33 (2009) 1361-1366]. Strathdee G; Ferguson S; Sim A; Brown R Leuk Res; 2010 May; 34(5):685-6. PubMed ID: 20006998 [No Abstract] [Full Text] [Related]
34. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. Passegué E; Wagner EF EMBO J; 2000 Jun; 19(12):2969-79. PubMed ID: 10856241 [TBL] [Abstract][Full Text] [Related]
35. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. Yasuda T; Shirakata M; Iwama A; Ishii A; Ebihara Y; Osawa M; Honda K; Shinohara H; Sudo K; Tsuji K; Nakauchi H; Iwakura Y; Hirai H; Oda H; Yamamoto T; Yamanashi Y J Exp Med; 2004 Dec; 200(12):1681-7. PubMed ID: 15611294 [TBL] [Abstract][Full Text] [Related]
36. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Drexler HG Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433 [TBL] [Abstract][Full Text] [Related]
37. Role for transcription Pax5A factor in maintaining commitment to the B cell lineage by selective inhibition of granulocyte-macrophage colony-stimulating factor receptor expression. Chiang MY; Monroe JG J Immunol; 2001 May; 166(10):6091-8. PubMed ID: 11342627 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338 [TBL] [Abstract][Full Text] [Related]
39. [Methylation status of JunB and CDH13 gene promoter in CD34(+)CD38(-) chronic myelogenous leukemia cells]. Wang XJ; Li J; Fu BJ; Guo LL; Zhang JH; Huang SA Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1405-8. PubMed ID: 20030915 [TBL] [Abstract][Full Text] [Related]